The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

Tech in AsiaAsia

Indian Institute of Science venom drug startup raises $2.7m

11.05

Venomics AI uses molecular sequencing, AI, and lab testing to identify venom-derived molecules that could be developed into drug candidates.

Funding & deals

Read at Tech in Asia ↗

One letter a week, starting soon.

Latest

Indian Institute of Science venom drug startup raises $2.7m

Related

AsiaAI chip startup Tenspresso seeks $50m at $500m valuation Tech in Asia

AsiaGoogle plans $15b Malaysia data center push to meet AI demand Tech in Asia

AsiaMeta acquires AI coding startup Conductor Tech in Asia

AsiaMapping Japan’s prominent cleantech startups Tech in Asia

ValleyPhaze raises $8.75M to give AI agents remote access to powerful workstations SiliconANGLE

AsiaCleantech Startup altM Raises $10.3 Mn To Scale Manufacturing Inc42